Presentation TCT 2012 Practice Trends in the United States: Nonadherence to the Mitral Valve Guidelines Presenter: James Gammie October 23, 2012
Presentation TCT 2012 Attributes of the Perfect LAA Closure Device: What All the Companies Should Strive For Presenter: Horst Sievert October 23, 2012
Presentation TCT 2012 TCT-4. Impact of Catheter Fragmentation Followed by Local Intrapulmonary Thrombolysis in Acute High Risk Pulmonary Embolism as Primary Therapy: Acute and Long Term Outcomes Presenter: Bishav Garg October 23, 2012
Presentation TCT 2012 TCT-81. Long-term Safety and Efficacy of Percutaneous Left Ventricular Transapical Access and Closure for Structural Heart Disease Interventions Presenter: Chad Kliger October 23, 2012
Presentation TCT 2012 The Case for CT-FFR as the Optimal Screening Tool: Latest DEScover and DeFACTO Results Presenter: Jonathon Leipsic October 23, 2012
Presentation TCT 2012 TCT-49. A Comparison of 5 mg Prasugrel with 75 mg Clopidogrel in Very Elderly Coronary Artery Disease Patients: Pharmacodynamics and Rates of High on-Treatment Reactivity Presenter: Joseph Jakubowski October 23, 2012
Presentation TCT 2012 What Will It Take for Focal Therapy of Vulnerable Plaque to Become a Reality? Preclinical and Clinical Insights Presenter: Patrick Serruys October 23, 2012
Presentation TCT 2012 TCT-39. 6-month Angiographic Follow-up of the Novel DESolveTM Myolimus-eluting Bioresorbable Coronary Scaffold for the Treatment of Non-complex Coronary Lesions – Results from... Presenter: Ricardo Costa October 23, 2012